Publications

4536 Results

Paired Phase II Studies of Erlotinib/Bevacizumab in Advanced Bronchioloalveolar Carcinoma or in Never-Smokers with Advanced Non-Small-Cell Lung Cancer (NSCLC): SWOG S0635 and S0636

Authors
HL West;J Moon;A Wozniak;PC Mack;F Hirsch;MJ Bury;MS Kwong;DD Nguyen;DF Moore;J Miao;M Redman;K Kelly;DR Gandara
Journal / Conference
Clinical Lung Cancer Jan;19(1):84-92;
Year
2018
Research Committee(s)
Lung
PMID
PMID28801183
PMC
PMC5748264
Study Number(s)
S0635, S0636

Smoking, sex and non-small cell lung cancer: examination of steroid hormone receptors in lung tumor tissue in SWOG S0424

Authors
T-Y D Cheng;A Darke;M Redman;G Zirpoli;W Davis;R Ondracek;W Bshara;AR Omilian;R Kratzke;JR Molina;JM Kolesar;Y Chen;R MacRae;J Moon;P Mack;D Gandara;K Kelly;R Santella;K Albain;C Ambrosone
Journal / Conference
Journal of the National Cancer Institute Jul 1;110(7):734-742; Jan 13. doi: 10.1093/jnci/djx260. [Epub ahead of print]
Year
2018
Research Committee(s)
Lung
PMID
PMID29346580
PMC
PMC6037104
Study Number(s)
S0424

Phase 2 study of RCHOP, radioimmunotherapy and maintenance rituximab in untreated follicular lymphoma: SWOG S0801

Authors
P Barr;H Li;WR Burack;M Leblanc;S Smith;AK Gopal;JD Floyd;D Persky;O Press;RI Fisher;JW Friedberg
Journal / Conference
Lancet Haematology Mar;5(3):e102-e108; 2018 Jan 25 [Epub ahead of print]
Year
2018
Research Committee(s)
Lymphoma
PMID
PMID29396094
Study Number(s)
S0801

Impact of homologous recombination deficiency biomarkers on outcomes in patients with triple-negative breast cancer treated with doxorubicin-based adjuvant chemotherapy (SWOG S9313)

Authors
P Sharma;W Barlow;A Godwin;H Pathak;K Isakova;K Timms;A Hartman;R Wenstrup;H Linden;D Tripathy;G Hortobagyi;DF Hayes
Journal / Conference
Annals of Oncology Mar 1;29(3):654-660; Dec 23 [Epub ahead of print] 2017
Year
2018
Research Committee(s)
Breast
PMID
PMID29293876
Study Number(s)
SWOG-9313

Quality of life (QOL) during treatment with chemohormonal therapy: analysis of ECOG 3805 chemohormonal androgen ablation randomized trial in prostate cancer (CHAARTED)

Authors
A Morgans;Y Chen;C Sweeney;D Jarrad;E Plimack;B Gartrell;M Carducci;M Hussain;J Garcia;D Cella;R DiPaola;L Patrick-Miller
Journal / Conference
Journal of Clinical Oncology, Apr 10;36(11):1088-1095; Mar 9 [Epub ahead of print]
Year
2018
Research Committee(s)
Genitourinary
PMID
PMID29522362
PMC
PMC5891128
Study Number(s)
CTSU/E3805

Two-Year Trends Of Taxane-Induced Neuropathy In Women Enrolled In A Randomized Trial Of Acetyl-L-Carnitine (SWOG S0715)

Authors
DL Hershman;JM Unger;K Crew;C Till;H Greenlee;L Minasian;C Moinpour;DL Lew;L Fehrenbacher;JL Wade;S-F Wong;M Fisch;KS Albain
Journal / Conference
Journal of the National Cancer Institute Jun 1;110(6):669-676; 2018 Jan 18. doi: 10.1093/jnci/djx259. [Epub ahead of print]
Year
2018
Research Committee(s)
Symptom Control and Quality of Life
PMID
PMID29361042
PMC
PMC6005110
Study Number(s)
S0715

Drug interaction screening in SWOG Clinical Trials

Authors
D Hertz;R Siden;J Modlin;M Gabel;S-F Wong
Journal / Conference
American Journal of Health-System Pharmacy May 15;75(10):607-612
Year
2018
Research Committee(s)
Multiple sites
PMID
PMID29748299

Lenalidomide consolidation benefits patients with CLL receiving chemoimmunotherapy: results for CALGB 10404 (Alliance)

Authors
JC Byrd;AS Ruppert;NA Heerema;AE Halvorson;M Boyd;E Hoke;MR Smith;JE Godwin;S Couban;TA Fehniger;M Thirman;M Tallman;F Appelbaum;RM Stone;S Robinson;JE Chang;SJ Mandrekar;RA Larson
Journal / Conference
Blood Advances, Jul 24;2(14):1705-1718
Year
2018
Research Committee(s)
Leukemia
PMID
PMID30030269
PMC
PMC6058242
Study Number(s)
C10404

Immediate post TURBT instillation of gemcitabine vs saline for suspected low grade bladder cancer: SWOG S0337

Authors
E Messing;C Tangen;SP Lerner;D Sahasrabudhe;T Koppie;DP Wood;PC Mack;R Svatek;C Evans;K Hafez;D Culkin;T Brand;L Karsh;J Holzbeierlein;SS Wilson;G Wu;M Plets;NJ Vogelzang;IM Thompson
Journal / Conference
JAMA May 8;319(18):1880-1888
Year
2018
Research Committee(s)
Genitourinary
PMID
PMID29801011
Study Number(s)
S0337

Bone turnover biomarkers identify unique prognostic risk groups in men with castration resistant prostate cancer and skeletal metastases: results from SWOG S0421

Authors
PN Lara;M Plets;C Tangen;E Gertz;N Vogelzang;M Hussain;P Twardowski;M Garzotto;JP Monk;M Carducci;A Goldkorn;PC Mack;DI Quinn;IM Thompson;M Van Loan
Journal / Conference
Cancer Treatment and Research Communications
Year
2018
Research Committee(s)
Genitourinary
Study Number(s)
S0421